SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    David J. Handelsman, Endocrinology: Adult and Pediatric, 2016,

    CrossRef

  2. 2
    Ilpo T. Huhtaniemi, Editorial Comment on “Use of Hormone Testing for the Diagnosis and Evaluation of Male Hypogonadism and Monitoring of Testosterone Therapy: Application of Hormone Testing Guideline Recommendations in Clinical Practice”, The Journal of Sexual Medicine, 2015, 12, 9
  3. 3
    Farid Saad, Aksam Yassin, Ahmad Haider, Gheorghe Doros, Louis Gooren, Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men, Korean Journal of Urology, 2015, 56, 4, 310

    CrossRef

  4. 4
    A Morgentaler, J McGettigan, Q Xiang, T M Danoff, E M Gould, Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial, International Journal of Impotence Research, 2015, 27, 2, 41

    CrossRef

  5. 5
    E. F. Shortridge, P. Polzer, P. Donga, R. L. Wade, Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan, International Journal of Clinical Practice, 2015, 69, 7
  6. 6
    G. I. Hackett, Testosterone Replacement Therapy and Mortality in Older Men, Drug Safety, 2015,

    CrossRef

  7. 7
    Matthias Oelke, Rajesh Shinghal, Angelina Sontag, Simin K. Baygani, Craig F. Donatucci, Time to Onset of Clinically Meaningful Improvement with Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Analysis of Data Pooled from 4 Pivotal, Double-Blind, Placebo Controlled Studies, The Journal of Urology, 2015, 193, 5, 1581

    CrossRef

  8. 8
    David Muram, Xiang Zhang, Zhanglin Cui, Alvin M. Matsumoto, Use of Hormone Testing for the Diagnosis and Evaluation of Male Hypogonadism and Monitoring of Testosterone Therapy: Application of Hormone Testing Guideline Recommendations in Clinical Practice, The Journal of Sexual Medicine, 2015, 12, 9
  9. 9
    Prasanth Surampudi, Ronald S Swerdloff, Christina Wang, An update on male hypogonadism therapy, Expert Opinion on Pharmacotherapy, 2014, 15, 9, 1247

    CrossRef

  10. 10
    Stephen E Borst, Jonathan J Shuster, Baiming Zou, Fan Ye, Huanguang Jia, Anita Wokhlu, Joshua F Yarrow, Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis, BMC Medicine, 2014, 12, 1, 211

    CrossRef

  11. 11
    Alvaro Morales, Determining the Role of Testosterone Deficiency in Sexual Function: The Beginning of the End or the End of the Beginning?, European Urology, 2014, 65, 1, 113

    CrossRef

  12. 12
    E. F. Shortridge, P. Polzer, P. Donga, C. M. Blanchette, Y. Fang, C. Burudpakdee, B. Carswell, Experiences and treatment patterns of hypogonadal men in a U.S. health system, International Journal of Clinical Practice, 2014, 68, 10
  13. 13
    Craig Donatucci, Zhanglin Cui, Yun Fang, David Muram, Long-Term Treatment Patterns of Testosterone Replacement Medications, The Journal of Sexual Medicine, 2014, 11, 8
  14. 14
    Jason R. Kovac, Saneal Rajanahally, Ryan P. Smith, Robert M. Coward, Dolores J. Lamb, Larry I. Lipshultz, Patient Satisfaction with Testosterone Replacement Therapies: The Reasons Behind the Choices, The Journal of Sexual Medicine, 2014, 11, 2
  15. 15
    Kevin C.J. Yuen, Testosterone and cardiovascular disease, Cardiovascular Endocrinology, 2014, 3, 4, 117

    CrossRef

  16. 16
    Abdulmaged M. Traish, Testosterone and weight loss, Current Opinion in Endocrinology & Diabetes and Obesity, 2014, 21, 5, 313

    CrossRef

  17. 17
    Alvaro Morales, Testosterone Deficiency Syndrome: An overview with emphasis on the diagnostic conundrum, Clinical Biochemistry, 2014, 47, 10-11, 960

    CrossRef